Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study
Leighl, N B, Bennouna, J, Yi, J, Moore, N, Hambleton, J, Hurwitz, H
Published in British journal of cancer (01.02.2011)
Published in British journal of cancer (01.02.2011)
Get full text
Journal Article
A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer
Chen, H, Modiano, M R, Neal, J W, Brahmer, J R, Rigas, J R, Jotte, R M, Leighl, N B, Riess, J W, Kuo, C J, Liu, L, Gao, B, DiCioccio, A T, Adjei, A A, Wakelee, H A
Published in British journal of cancer (04.02.2014)
Published in British journal of cancer (04.02.2014)
Get full text
Journal Article
An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancer
Horgan, A.M., Bradbury, P.A., Amir, E., Ng, R., Douillard, J.Y., Kim, E.S., Shepherd, F.A., Leighl, N.B.
Published in Annals of oncology (01.08.2011)
Published in Annals of oncology (01.08.2011)
Get full text
Journal Article
Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer
Leighl, N B, Shepherd, F A, Zawisza, D, Burkes, R L, Feld, R, Waldron, J, Sun, A, Payne, D, Bezjak, A, Tattersall, M H N
Published in British journal of cancer (03.06.2008)
Published in British journal of cancer (03.06.2008)
Get full text
Journal Article
A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
Diaz-Padilla, I, Siu, L L, San Pedro-Salcedo, M, Razak, A R A, Colevas, A D, Shepherd, F A, Leighl, N B, Neal, J W, Thibault, A, Liu, L, Lisano, J, Gao, B, Lawson, E B, Wakelee, H A
Published in British journal of cancer (07.08.2012)
Published in British journal of cancer (07.08.2012)
Get full text
Journal Article
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial
Hui, R., Garon, E.B., Goldman, J.W., Leighl, N.B., Hellmann, M.D., Patnaik, A., Gandhi, L., Eder, J.P., Ahn, M.-J., Horn, L., Felip, E., Carcereny, E., Rangwala, R., Lubiniecki, G.M., Zhang, J., Emancipator, K., Roach, C., Rizvi, N.A.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer
Lim, C., Tsao, M.S., Le, L.W., Shepherd, F.A., Feld, R., Burkes, R.L., Liu, G., Kamel-Reid, S., Hwang, D., Tanguay, J., da Cunha Santos, G., Leighl, N.B.
Published in Annals of oncology (01.07.2015)
Published in Annals of oncology (01.07.2015)
Get full text
Journal Article
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer
Schoenfeld, A.J., Antonia, S.J., Awad, M.M., Felip, E., Gainor, J., Gettinger, S.N., Hodi, F.S., Johnson, M.L., Leighl, N.B., Lovly, C.M., Mok, T., Perol, M., Reck, M., Solomon, B., Soria, J.-C., Tan, D.S.W., Peters, S., Hellmann, M.D.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival
Wakeam, E, Acuna, S.A, Leighl, N.B, Giuliani, M.E, Finlayson, S.R.G, Varghese, T.K, Darling, G.E
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2017)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2017)
Get full text
Journal Article
Canadian consensus: a new systemic treatment algorithm for advanced EGFR- mutated non-small-cell lung cancer
Melosky, B, Banerji, S, Blais, N, Chu, Q, Juergens, R, Leighl, N B, Liu, G, Cheema, P
Published in Current oncology (Toronto) (01.04.2020)
Published in Current oncology (Toronto) (01.04.2020)
Get full text
Journal Article
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
Fung, A.S., Graham, D.M., Chen, E.X., Stockley, T.L., Zhang, T., Le, L.W., Albaba, H., Pisters, K.M., Bradbury, P.A., Trinkaus, M., Chan, M., Arif, S., Zurawska, U., Rothenstein, J., Zawisza, D., Effendi, S., Gill, S., Sawczak, M., Law, J.H., Leighl, N.B.
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2021)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2021)
Get full text
Journal Article
Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR- mutated non-small-cell lung cancer
Cheema, P K, Gomes, M, Banerji, S, Joubert, P, Leighl, N B, Melosky, B, Sheffield, B S, Stockley, T, Ionescu, D N
Published in Current oncology (Toronto) (01.12.2020)
Published in Current oncology (Toronto) (01.12.2020)
Get full text
Journal Article
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
Gosney, J.R., Paz-Ares, L., Jänne, P., Kerr, K.M., Leighl, N.B., Lozano, M.D., Malapelle, U., Mok, T., Sheffield, B.S., Tufman, A., Wistuba, I.I., Peters, S.
Published in ESMO open (01.08.2023)
Published in ESMO open (01.08.2023)
Get full text
Journal Article
Management of egfr tki-induced dermatologic adverse events
Melosky, B, Leighl, N B, Rothenstein, J, Sangha, R, Stewart, D, Papp, K
Published in Current oncology (Toronto) (01.04.2015)
Published in Current oncology (Toronto) (01.04.2015)
Get full text
Journal Article
Diagnostic patterns of non-small-cell lung cancer at Princess Margaret Cancer Centre
Nadjafi, M, Sung, M R, Santos, G D C, Le, L W, Hwang, D M, Tsao, M S, Leighl, N B
Published in Current oncology (Toronto) (01.10.2020)
Published in Current oncology (Toronto) (01.10.2020)
Get full text
Journal Article